Circulating tumor cells as a surrogate marker for determining response to chemotherapy in Japanese patients with metastatic colorectal cancer

Cancer Science

Volumn 102, Issue 6, 2011, Pages 1188-1192

  Matsusaka, Satoshi ^a,b   Suenaga, Mitsukuni ^a   Mishima, Yuji ^b   Kuniyoshi, Ryoko ^b   Takagi, Koichi ^a   Terui, Yasuhito ^a,b   Mizunuma, Nobuyuki ^a   Hatake, Kiyohiko ^a,b  

^a CANCER INSTITUTE HOSPITAL   (Japan)

^b CANCER CHEMOTHERAPY CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; OXALIPLATIN;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER SURVIVAL; CIRCULATING TUMOR CELL; COLORECTAL CANCER; DISEASE MARKER; FEMALE; HUMAN; HUMAN CELL; IMMUNOMAGNETIC SEPARATION; JAPANESE; MAJOR CLINICAL STUDY; MALE; PATIENT IDENTIFICATION; PRIORITY JOURNAL; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC AGENTS; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASTIC CELLS, CIRCULATING; ORGANOPLATINUM COMPOUNDS; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 79956218109     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2011.01926.x     Document Type: Article

References (15)

1. Pantel K, Brakenhoff RH. Dissecting the metastatic cascade. Nat Rev Cancer 2004; 4: 448-56.
2. Ring A, Smithe IE, Dowsett M. Circulating tumour cells in breast cancer. Lancet Oncol 2004; 5: 79-88.
3. Smerage JB, Hayes DF. The measurement and therapeutic implications of circulating tumour cells in breast cancer. Br J Cancer 2006; 94: 8-12.
4. Müller V, Stahmann N, Riethdorf S et al. Circulating tumor cells in breast cancer: correlation to bone marrow micrometastases, heterogeneous response to systemic therapy and low proliferative activity. Clin Cancer Res 2005; 11: 3678-85.
5. Wiedswang G, Borgen E, Schirmer C et al. Comparison of the clinical significance of occult tumor cells in blood and bone marrow in breast cancer. Int J Cancer 2006; 118: 2013-9.
6. Balic M, Dandachi N, Hofmann G et al. Comparison of two methods for enumerating circulating tumor cells in carcinoma patients. Cytometry B Clin Cytom 2005; 68: 25-30.
7. Cruz I, Ciudad J, Cruz JJ et al. Evaluation of multiparameter flow cytometry for the detection of breast cancer tumor cells in blood samples. Am J Clin Pathol 2005; 123: 66-74.
8. Cohen SJ, Punt CJ, Iannotti N et al. Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. J Clin Oncol 2008; 31: 3213-21.
9. Sorbye H, Dahl O. Carcinoembryonic antigen surge in metastatic colorectal cancer patients responding to oxaliplatin combination chemotherapy: implications for tumor marker monitoring and guidelines. J Clin Oncol 2003; 21: 4466-7.
10. Allan AL, Vantyghem SA, Tuck AB, Chambers AF, Chin-Yee IH, Keeney M. Detection and quantification of circulating tumor cells in mouse models of human breast cancer using immunomagnetic enrichment and multiparameter flow cytometry. Cytometry A 2005; 65: 4-14.
11. Locker GY, Hamilton S, Harris J et al. ASCO 2006 update of recommendation for the use of tumor markers in gastrointestinal cancer. J Clin Oncol 2006; 33: 5313-27.
12. Cristofanilli M, Budd GT, Ellis MJ et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 2004; 351: 781-91.
13. Hayes DF, Cristofanilli M, Budd GT et al. Circulating tumor cells at each follow-up time point during therapy of metastatic breast cancer patients predict progression-free and overall survival. Clin Cancer Res 2006; 12: 4218-24.
14. Shaffer DR, Leversha MA, Danila DC et al. Circulating tumor cell analysis in patients with progressive castration-resistant prostate cancer. Clin Cancer Res 2007; 13: 2023-9.
15. Matsusaka S, Chin K, Mizunuma N et al. Circulating tumor cells as a surrogate marker for determining response to chemotherapy in patients with advanced gastric cancer. Cancer Sci 2010; 101: 1067-71.